Clinical Trial Update: Safety and Acceptability Study of Oral Emtricitabine/Tenofovir Disoproxil Fumarate Tablet and Rectally-Applied Tenofovir Reduced-Glycerin 1% Gel [Phase 2]

View source ↗

Summary

Phase 2 safety and acceptability study of oral emtricitabine/tenofovir disoproxil fumarate and rectally applied tenofovir gel completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• emtricitabine/tenofovir disoproxil fumarate (oral) (emtricitabine/tenofovir disoproxil fumarate)
• tenofovir reduced-glycerin 1% gel (rectal) (tenofovir reduced-glycerin 1% gel)

Snippet

Sponsor: CONRAD | Conditions: HIV | Phase 2 | Status: COMPLETED | Results posted: 2017-02-01